Project Grant HT94252410146
Award Date
7/1/24
Completion Date
6/30/28
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $6,699,872.00 Project Grant to the University of Pittsburgh on September 30, 2024. The grant, titled "MICROGLIAL BREAKTHROUGHS IN LONGEVITY, AGING, AND SENESCENCE AFTER TBI (MICROBLAST)", will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The University of Pittsburgh, a major public...
The University of Pittsburgh was awarded a $2,347,592 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop 4D OXY-WAVELET MRI as a non-invasive biomarker for assessing brain mitochondrial function in vivo. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The University of Pittsburgh has been awarded a $569,851 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund research to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The research is expected to be conducted over a four-year period from July...
This $2,699,157 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, supports research to evaluate the effectiveness of a traumatic brain injury (TBI) whole blood test in improving assessment and triage for patients with mild TBI presenting to civilian emergency departments. The primary recipient, the University of Pittsburgh, will conduct this research over a performance period from July 1, 2025 to June 30,...
This $392,119 Project Grant was awarded on September 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The grant supports establishing statin/MBV-based therapies for enhancing optic nerve regeneration after traumatic optic neuropathy. The University of Pittsburgh, a major recipient of federal research grants, will leverage its academic expertise and research infrastructure to conduct this basic and...
This federal Project Grant award of $6,292,954.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the "MONITORING AND MITIGATION OF NEUROLOGICAL INJURIES TO OPTIMIZE RESILIENCE AFTER REPETITIVE HEAD IMPACTS (MONITOR RHI)" research initiative. The grant was awarded to the University of Rochester, a leading private research institution, to conduct advanced biomedical research focused on transforming healthcare...
This federal Project Grant award in the amount of $1,572,933.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is being used to fund research at the University of Pittsburgh aimed at targeting lysosomal pathways to improve host immunity following coronavirus infections. The research seeks to explore innovative approaches to disease prevention, diagnosis, treatment, and management of conditions relevant to military...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...
The University of Pittsburgh - Of The Commonwealth System of Higher Education was awarded a $1,148,334.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop viral delivery strategies for targeted hair cell regeneration. The award, which began on May 15, 2025 and has an ultimate completion date of May 14, 2028, supports advanced biomedical research initiatives focused on transforming healthcare for military service...